CP-945,598: Clinical Trials

6 completed. 6 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	6	Completed 6

Follow CP-945,598: new trials by email Literature Review of CP-945,598 trials Research Report on CP-945,598

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Role of Endocannabinoids in Insulin Production and Action Nabilone, CP-945,598, hyperglycemic clamp - Healthy Volunteers	Phase 1	Completed	National Institute on Aging (NIA)	45	2012-01-05	2026-11-05
Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug CP-945,598 - Obesity, Hepatic Insufficiency	Phase 1	Completed	Pfizer	24	2008-04-01	2009-08-27
Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug CP-945,598 - Obesity	Phase 1	Completed	Pfizer	28	2008-04-01	2009-08-13
Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety CP-945,598 - Obesity	Phase 1	Completed	Pfizer	28	2007-06-01	2009-08-10
Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug CP-945,598 - Obesity	Phase 1	Completed	Pfizer	17	2007-06-01	2009-08-13
Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics CP-945,598 - Obesity	Phase 1	Completed	Pfizer	28	2007-03-01	2009-09-17

Conditions studied

Obesity (5)  ·  Hepatic Insufficiency (1)  ·  Insulin Resistance (1)

Sponsors

Pfizer (5)  ·  National Institute on Aging (NIA) (1)

Countries

United States (6)

Top investigators

Chee W Chia, M.D. (1)